Literature DB >> 19380465

Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection.

Amy Croswell1, Elad Amir, Paul Teggatz, Melissa Barman, Nita H Salzman.   

Abstract

The impact of antibiotics on the host's protective microbiota and the resulting increased susceptibility to mucosal infection are poorly understood. In this study, antibiotic regimens commonly applied to murine enteritis models are used to examine the impact of antibiotics on the intestinal microbiota, the time course of recovery of the biota, and the resulting susceptibility to enteric Salmonella infection. Molecular analysis of the microbiota showed that antibiotic treatment has an impact on the colonization of the murine gut that is site and antibiotic dependent. While combinations of antibiotics were able to eliminate culturable bacteria, none of the antibiotic treatments were effective at sterilizing the intestinal tract. Recovery of total bacterial numbers occurs within 1 week after antibiotic withdrawal, but alterations in specific bacterial groups persist for several weeks. Increased Salmonella translocation associated with antibiotic pretreatment corrects rapidly in association with the recovery of the most dominant bacterial group, which parallels the recovery of total bacterial numbers. However, susceptibility to intestinal colonization and mucosal inflammation persists when mice are infected several weeks after withdrawal of antibiotics, correlating with subtle alterations in the intestinal microbiome involving alterations of specific bacterial groups. These results show that the colonizing microbiotas are integral to mucosal host protection, that specific features of the microbiome impact different aspects of enteric Salmonella pathogenesis, and that antibiotics can have prolonged deleterious effects on intestinal colonization resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380465      PMCID: PMC2708550          DOI: 10.1128/IAI.00006-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Review and re-analysis of domain-specific 16S primers.

Authors:  G C Baker; J J Smith; D A Cowan
Journal:  J Microbiol Methods       Date:  2003-12       Impact factor: 2.363

2.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

3.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.

Authors:  Inna Sekirov; Nicola M Tam; Maria Jogova; Marilyn L Robertson; Yuling Li; Claudia Lupp; B Brett Finlay
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

5.  Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract.

Authors:  Melissa Barman; David Unold; Kathleen Shifley; Elad Amir; Kueichun Hung; Nicolaas Bos; Nita Salzman
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

6.  Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota.

Authors:  Jennifer M Bates; Janie Akerlund; Erika Mittge; Karen Guillemin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

7.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Authors:  Claudia Lupp; Marilyn L Robertson; Mark E Wickham; Inna Sekirov; Olivia L Champion; Erin C Gaynor; B Brett Finlay
Journal:  Cell Host Microbe       Date:  2007-08-16       Impact factor: 21.023

8.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

9.  Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface.

Authors:  Shipra Vaishnava; Cassie L Behrendt; Anisa S Ismail; Lars Eckmann; Lora V Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

10.  The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors:  Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal:  PLoS Biol       Date:  2008-11-18       Impact factor: 8.029

View more
  138 in total

Review 1.  The potter's wheel: the host's role in sculpting its microbiota.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

2.  Which species are in your feces?

Authors:  Colby Zaph
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Gut immune maturation depends on colonization with a host-specific microbiota.

Authors:  Hachung Chung; Sünje J Pamp; Jonathan A Hill; Neeraj K Surana; Sanna M Edelman; Erin B Troy; Nicola C Reading; Eduardo J Villablanca; Sen Wang; Jorge R Mora; Yoshinori Umesaki; Diane Mathis; Christophe Benoist; David A Relman; Dennis L Kasper
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

4.  Evidence of uncultivated bacteria in the adult female bladder.

Authors:  Alan J Wolfe; Evelyn Toh; Noriko Shibata; Ruichen Rong; Kimberly Kenton; MaryPat Fitzgerald; Elizabeth R Mueller; Paul Schreckenberger; Qunfeng Dong; David E Nelson; Linda Brubaker
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

5.  Topical Antimicrobial Treatments Can Elicit Shifts to Resident Skin Bacterial Communities and Reduce Colonization by Staphylococcus aureus Competitors.

Authors:  Adam J SanMiguel; Jacquelyn S Meisel; Joseph Horwinski; Qi Zheng; Elizabeth A Grice
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

6.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

7.  Salmonella Fimbrial Protein FimH Is Involved in Expression of Proinflammatory Cytokines in a Toll-Like Receptor 4-Dependent Manner.

Authors:  Kei-Ichi Uchiya; Yurie Kamimura; Ayumi Jusakon; Toshiaki Nikai
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

8.  Fecal microbiomes of non-human primates in Western Uganda reveal species-specific communities largely resistant to habitat perturbation.

Authors:  Aleia I McCord; Colin A Chapman; Geoffrey Weny; Alex Tumukunde; David Hyeroba; Kelly Klotz; Avery S Koblings; David N M Mbora; Melissa Cregger; Bryan A White; Steven R Leigh; Tony L Goldberg
Journal:  Am J Primatol       Date:  2013-11-27       Impact factor: 2.371

9.  Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis.

Authors:  Lauren E Ritchie; Joseph M Sturino; Raymond J Carroll; Lloyd W Rooney; M Andrea Azcarate-Peril; Nancy D Turner
Journal:  FEMS Microbiol Ecol       Date:  2015-01-14       Impact factor: 4.194

Review 10.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.